Prostate Active Surveillance Study
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of Washington
- Study ID
- NCT00756665
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- MALE
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The Prostate Active Surveillance Study (PASS) is a research study for men who have chosen active surveillance as a management plan for their prostate cancer. Active surveillance is defined as close monitoring of prostate cancer with the offer of treatment if there are changes in test results. This study seeks to discover markers that will identify cancers that are more aggressive from those tumors that grow slowly.
Key Dates
- Start date
- Jul 31, 2008
- Status verified
- Jan 2026
- Primary completion
- Sep 30, 2029
- Completion
- Sep 30, 2032
Study Design
- Enrollment
- 3,000 participants (estimated)
Central Contacts
- Lisa Newcomb, PhD
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94143 | Peter R. Carroll, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| Veterans Affairs San Francisco Health Care System | San Francisco | California | 94121 | Matthew R. Cooperberg, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| Stanford University | Stanford | California | 94305 | James D. Brooks, MD (PRINCIPAL_INVESTIGATOR) |
| Emory University | Atlanta | Georgia | 30322 | Martin G. Sanda, MD (PRINCIPAL_INVESTIGATOR) |
| Beth Israel Deaconess Medical Center/Harvard Medical School | Boston | Massachusetts | 02215 | Andrew A. Wagner, MD (PRINCIPAL_INVESTIGATOR) |
| University of Michigan | Ann Arbor | Michigan | 48105 | Todd M. Morgan, MD (PRINCIPAL_INVESTIGATOR) |
| University of Texas Health Science Center, San Antonio | San Antonio | Texas | 78229 | Michael A. Liss, MD, MAS (PRINCIPAL_INVESTIGATOR) |
| Eastern Virginia Medical School | Norfolk | Virginia | 23502 | Robert W. Given, MD (PRINCIPAL_INVESTIGATOR) |
| University of Washington | Seattle | Washington | 98195 | Daniel W. Lin, MD (PRINCIPAL_INVESTIGATOR) |
| Veterans Affairs Puget Sound Health Care System | Seattle | Washington | 98108 | Atreya Dash, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in San Francisco, CA
By condition
By specialty
By research site
Related Studies
- HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate CancerPHASE1/PHASE2 · Recruiting · The Methodist Hospital Research Institute · Houston, Texas
- Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionPHASE1/PHASE2 · Recruiting · Blue Earth Therapeutics Ltd · Miami, Florida
- RecoverPC: Relugolix vs GnRH Agonist in Quality of LifePHASE2 · Recruiting · Dana-Farber Cancer Institute · Boston, Massachusetts
- Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical ProstatectomyPHASE3 · Recruiting · Clarity Pharmaceuticals Ltd · Birmingham, Alabama